Benzylidene ketal derivatives were investigated as selective M-2 receptor a
ntagonists for the treatment of Alzheimer's disease. Compound 10 was discov
ered to have subnanomolar M-2 receptor affinity and 100-fold selectivity ag
ainst other muscarinic receptors. Also, 10 demonstrated in vivo efficacy in
rodent models of muscarinic activity and cognition. (C) 2000 Elsevier Scie
nce Ltd. All rights reserved.